Literature DB >> 2970687

Effect of photodynamic therapy on blood flow in normal and tumor vessels.

T J Wieman1, T S Mang, V H Fingar, T G Hill, M W Reed, T S Corey, V Q Nguyen, E R Render.   

Abstract

The aim of this series of experiments was to determine the dynamic blood flow changes that occur in normal and neoplastic tissues during photodynamic therapy. Mice bearing SMT-F tumors and rats with transplanted chondrosarcomas were injected with graded doses of dihematoporphyrin ether. Studies of changes in single-vessel and whole-tumor blood flow were carried out with 630 nm light activation. A helium neon laser Doppler velocimeter was used to stimulate dihematoporphyrin ether, as well as to measure changes in flow velocity in both single-vessel and whole-tumor models. There was a reduction of flow velocity in all vessels and tumors in animals injected with 1 to 40 mg/kg dihematoporphyrin ether intraperitoneally. The extent of flow reduction was related to drug dose administered. Decreases in blood flow began within 10 seconds of light stimulation and were maximal within 5 minutes. Both normal and tumor vessels responded similarly. We conclude that photodynamic therapy leads to significant microcirculatory changes that may be pertinent to the mechanism of tumor necrosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2970687

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  14 in total

1.  Enhancement of photodynamic therapy in gastric cancer cells by removal of iron.

Authors:  W C Tan; N Krasner; P O'Toole; M Lombard
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

Review 2.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  PBPK modeling-based optimization of site-specific chemo-photodynamic therapy with far-red light-activatable paclitaxel prodrug.

Authors:  Mengjie Li; Luong Nguyen; Bharathiraja Subramaniyan; Moses Bio; Cody J Peer; Jessica Kindrick; William D Figg; Sukyung Woo; Youngjae You
Journal:  J Control Release       Date:  2019-07-09       Impact factor: 9.776

Review 4.  Malignant central airway obstruction.

Authors:  Lakshmi Mudambi; Russell Miller; George A Eapen
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

5.  Neuropilin-1 targeting photosensitization-induced early stages of thrombosis via tissue factor release.

Authors:  Denise Bechet; Loraine Tirand; Béatrice Faivre; François Plénat; Corinne Bonnet; Thierry Bastogne; Céline Frochot; François Guillemin; Muriel Barberi-Heyob
Journal:  Pharm Res       Date:  2010-01-20       Impact factor: 4.200

6.  Non-invasive monitoring of photodynamic therapy with 99technetium HMPAO scintigraphy.

Authors:  R B Moore; J D Chapman; A D Mokrzanowski; M R Arnfield; M S McPhee; A J McEwan
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640

7.  Verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy.

Authors:  L Gossner; H Wittke; A Warzecha; R Sroka; H Ernst; M Meier; C Ell
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

8.  Photodynamic therapy-induced alterations in interstitial fluid pressure, volume and water content of an amelanotic melanoma in the hamster.

Authors:  M Leunig; A E Goetz; F Gamarra; G Zetterer; K Messmer; R K Jain
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

9.  A study of the effects of photodynamic therapy on the normal tissues of the rabbit jaw.

Authors:  M Meyer; P Speight; S G Bown
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

10.  The effect of aminolaevulinic acid-induced, protoporphyrin IX-mediated photodynamic therapy on the cremaster muscle microcirculation in vivo.

Authors:  J Leveckis; N J Brown; M W Reed
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.